1998

Started production of Ranitidine HCL & in short spasm of time has become one of the largest manufactured in the world

1992

Established Saraca Laboratories with an aim to manufacture Bulk Drugs & Intermediates

MILESTONES

1981

Dr. Reddy set up the flagship company Virchow Laboratories Ltd.

1995

WHO GMP, EU GMP certification

2001

Launching Bio-pharmaceutical company Virchow biotech focusing on wide range of biological & biogenetics

2001

EDQM certification. Become largest producer of  Sulphamethoxazole. Servicing 90% worldwide requirement

2003

US FDA Approval

2007

First to launch indigenous generic PTH Teripartide and Interferon & Peg interferon in India

2007

Launched dedicated Advanced wound care division, Hemostats and unique SAP (Sub-atmospheric pressure) therapy

2008

Launch Virchow Healthcare Ltd. International marketing cell 

2008

Signed MOU with then no.2 Pharma Company in India to market Virchow’s indigenously developed recombinant therapeutic protein for Osteoporosis treatment and Interferon, Peglitated Interferon & Ribavirin for Hepatitis management

2010

First breakthrough in CIS region

2011

Our-licensing agreement with leading pharma companies to market biotech range

2012

Launched domestic marketing arm under the banner of flagship company Virchow laboratories Ltd. With cost effective, auality solution for complete Hepatitis and Osteoporosis management

2013

Entered Latin & South America region

2015

Received PIC/S approval for plant

The journey continues...